Literature DB >> 8500478

A cluster of four cases of Mycobacterium haemophilum infection.

T E Kiehn1, M White, K J Pursell, N Boone, M Tsivitis, A E Brown, B Polsky, D Armstrong.   

Abstract

Four cases of infection with Mycobacterium haemophilum occurred at a single hospital in a seven-month period. Only 22 cases have been reported since 1976. All four patients were immunocompromised; two had AIDS and two were the first known recipients of allogeneic bone marrow transplants (BMT) to develop the infection. One BMT recipient died of Mycobacterium haemophilum pneumonia. The organism requires hemin or ferric ammonium citrate and incubation of media at 30 degrees C for optimum growth. Clinicians and microbiologists should consider infection with Mycobacterium haemophilum, particularly when specimens are from immunocompromised patients with unexplained illness and/or when acid-fast bacilli are seen on smear.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500478     DOI: 10.1007/BF01967586

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections.

Authors:  M E McBride; A H Rudolph; J A Tschen; P Cernoch; J Davis; B A Brown; R J Wallace
Journal:  Arch Dermatol       Date:  1991-02

2.  Unusual mycobacteria in 5 cases of opportunistic infections.

Authors:  A Mezo; F Jennis; S W McCarthy; D J Dawson
Journal:  Pathology       Date:  1979-07       Impact factor: 5.306

3.  Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome.

Authors:  P L Rogers; R E Walker; H C Lane; F G Witebsky; J A Kovacs; J E Parrillo; H Masur
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965

4.  The skin and immunosuppression.

Authors:  B K Walder; D Jeremy; J A Charlesworth; G J Macdonald; B A Pussell; M R Robertson
Journal:  Australas J Dermatol       Date:  1976-12       Impact factor: 2.875

5.  Skin lesions caused by Mycobacterium haemophilum.

Authors:  B R Davis; J Brumbach; W J Sanders; E Wolinsky
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

6.  Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS.

Authors:  L L Dever; J W Martin; B Seaworth; J H Jorgensen
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

7.  Mycobacterium haemophilum infection in a patient with acquired immune deficiency syndrome.

Authors:  B M Males; T E West; W R Bartholomew
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

8.  Two cases of Mycobacterium haemophilum infection in Canada.

Authors:  L Thibert; F Lebel; B Martineau
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

9.  Mycobacterium haemophilum causing lymphadenitis in an otherwise healthy child.

Authors:  D J Dawson; Z M Blacklock; D W Kane
Journal:  Med J Aust       Date:  1981-09-19       Impact factor: 7.738

Review 10.  Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature.

Authors:  M Kristjansson; V M Bieluch; P D Byeff
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct
View more
  15 in total

1.  Nontuberculous Mycobacterial Infections of the Lung.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

2.  Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy.

Authors:  Z Samra; L Kaufmann; A Zeharia; S Ashkenazi; J Amir; J Bahar; U Reischl; L Naumann
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 3.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Mycobacterium haemophilum as a novel etiology of cervical lymphadenitis in an otherwise healthy adult patient.

Authors:  Theobald J C Minani; Michael A Saubolle; Edwin Yu; Zdenek Sussland
Journal:  J Clin Microbiol       Date:  2010-05-19       Impact factor: 5.948

Review 5.  Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.

Authors:  M A Saubolle; T E Kiehn; M H White; M F Rudinsky; D Armstrong
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

6.  Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis.

Authors:  T Tønjum; D B Welty; E Jantzen; P L Small
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

Review 7.  Mycobacterium haemophilum: an emerging pathogen.

Authors:  T E Kiehn; M White
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

8.  Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum.

Authors:  K Kikuchi; E M Bernard; T E Kiehn; D Armstrong; L W Riley
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Intracellular growth and cytotoxicity of Mycobacterium haemophilum in a human epithelial cell line (Hec-1-B).

Authors:  L J Fischer; F D Quinn; E H White; C H King
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum.

Authors:  E M Bernard; F F Edwards; T E Kiehn; S T Brown; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.